Defendant C is registered as a business entity that engages in wholesale and retail business, such as research reagents, with the trade name of F as the friendship of Defendant B.

The Plaintiff, as indicated in the following table, lent the sum of KRW 679.5 million to the above Defendant, as the Plaintiff was at the end of Defendant B’s false statement.

On October 24, 2016, 150,000 won from the date of lending 15% if the beneficiary university purchases and resells three of the medical freezings for medical use at the beneficiary university, which is going out of 49.5 million won on October 24, 2016, the distribution profit of 15% will be paid if it lends money.

2. The 10% profit will be paid in the event that the additional money is repaid by November 1, 11, and the 15% profit will be paid in the event that the repayment is made by November 30, 191.

On October 31, 2016, KRW 300,000,000 won is required to purchase goods on November 16, 2016 and pay for distribution profits.

11.To make payments until 30.30

November 17, 2016, KRW 60,000,000,000 4 November 21, 2016, 250,000,000 were able to kill other things.

New articles can be distributed up to 20% because they can be added to 250,000,000 won, and if they are extended to 12. 12. 30,000 won including 20% of the distribution profit.

On October 24, 2016, the Plaintiff issued the deposit account for the loan Nos. 1 and the electronic tax invoice in the name of F deposited the loan No. 1 into the new bank account (G) account in the name of Defendant C at the request of Defendant B. On the 26th of the same month, Defendant C issued the electronic tax invoice of the amount equivalent to the loan to D operated by the Plaintiff under the name of Defendant B.

Defendant B’s partial repayment of Defendant B incurred KRW 100 million out of the above loans to the Plaintiff on November 25, 2016.